Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Digital Realty Trust, Inc. (DLR) vs Revvity Inc (RVTY) Price & Performance

Digital Realty Trust, Inc.Trade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Digital Realty Trust, Inc. vs Revvity Inc — how do they compare? Digital Realty Trust, Inc. trades at $178.45 (market cap $65.32B), while Revvity Inc trades at $154.68 (market cap $16.98B). The key difference: Digital Realty Trust, Inc. is far larger — about 3.8× Revvity Inc's market cap, and Digital Realty Trust, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals — on Pluang, investors hold Digital Realty Trust, Inc. for 94 Days and Revvity Inc for 12 Days on average.

DLRRVTY
Market Cap
$65.32B$16.98B
Volume
2,563,9501,456,900
Sector
Real EstateHealth
52-Week High
$203.91$157.36
52-Week Low
$147.93$82.26
Typical Hold Time
94 Days12 Days
Enterprise Value
$84.03B$19.30B
Dividend Yield
2.77%0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Digital Realty Trust, Inc.

Digital Realty Trust (DLR) trades at $180.47, down 2.26% today, with a bearish technical signal despite strong analyst support. The data center REIT shows robust revenue growth to $6.11B in 2025 and expanding AI infrastructure partnerships, though valuation metrics remain elevated with a P/E of 85.89. Recent earnings show mixed results with Q2 2026 beating expectations by 150%.

DLR presents a compelling AI infrastructure play with strong growth prospects but faces valuation concerns and execution risks. The consensus price target of $222.35 suggests 23% upside potential, supported by 69% analyst buy ratings. Key risks include high leverage and competitive pressures in the rapidly expanding data center market.

Revvity Inc

Revvity (RVTY) trades at $154.33, up 0.48% on the day and near its 52-week high of $158.28. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and positive analyst upgrades reflect solid fundamentals. Key developments include the launch of a new Type 1 diabetes screening kit in Europe and the acquisition of Human Cell Design to bolster metabolic disease research, signaling growth in diagnostics and life sciences.

The outlook remains positive given consistent earnings outperformance and strategic expansions, though rich valuation multiples pose a risk if growth moderates. Investors face near-term headwinds from margin pressures in China and elevated P/E ratios, but institutional accumulation and a lack of sell ratings support a constructive bias for long-term holders.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLR
100% Buy0% Sell
Avg holding period · 94 Days
RVTY

No sentiment data available yet.

Top news

Latest headlines on both assets

About Digital Realty Trust, Inc.

Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.

Read more on DLR →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →